Fibrinogen inhibits neurite outgrowth via β3 integrin-mediated phosphorylation of the EGF receptor

被引:99
作者
Schachtrup, Christian
Lu, Paul
Jones, Leonard L.
Lee, Jae K.
Lu, Jerry
Sachs, Ben D.
Zhengt, Binhai
Akassoglou, Katerina [1 ]
机构
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
关键词
blood-brain barrier; regeneration; spinal cord injury; transactivation; scar;
D O I
10.1073/pnas.0704045104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Changes in the molecular and cellular composition of the CNS after injury or disease result in the formation of an inhibitory environment that inhibits the regeneration of adult mammalian CNS neurons. Although a dramatic change in the CNS environment after traumatic injury or disease is hemorrhage because of vascular rupture or leakage of the blood-brain barrier, the potential role for blood proteins in repair processes remains unknown. Here we show that the blood protein fibrinogen is an inhibitor of neurite outgrowth that is massively deposited in the spinal cord after injury. We show that fibrinogen acts as a ligand for beta 3 integrin and induces the transactivation of EGF receptor (EGFR) in neurons. Fibrinogen-mediated inhibition of neurite outgrowth is reversed by blocking either beta 3 integrin or phoshorylation of EGFR. Inhibition of Src family kinases that mediate the cross-talk between integrin and growth factor receptors rescue the fibrinogen-induced phosphorylation of EGFR. These results identify fibrinogen as the first blood-derived inhibitor of neurite outgrowth and suggest fibrinogen-induced EGFR transactivation on neuronal cells as a molecular link between vascular and neuronal damage in the CNS after injury.
引用
收藏
页码:11814 / 11819
页数:6
相关论文
共 56 条
[1]   Astrocyte-endothelial interactions at the blood-brain barrier [J].
Abbott, NJ ;
Rönnbäck, L ;
Hansson, E .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53
[2]  
Adams RA, 2004, MOL INTERV, V4, P163
[3]   The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease [J].
Adams, Ryan A. ;
Bauer, Jan ;
Flick, Matthew J. ;
Sikorski, Shoana L. ;
Nuriel, Tal ;
Lassmann, Hans ;
Degen, Jay L. ;
Akassoglou, Katerina .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (03) :571-582
[4]   Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy [J].
Adhami, Faisal ;
Liao, Guanghong ;
Morozov, Yury M. ;
Schloemer, Aryn ;
Schmithorst, Vincent J. ;
Lorenz, John N. ;
Dunn, R. Scott ;
Vorhees, Charles V. ;
Wills-Karp, Marsha ;
Degen, Jay L. ;
Davis, Roger J. ;
Mizushima, Noboru ;
Rakic, Pasko ;
Dardzinski, Bernard J. ;
Holland, Scott K. ;
Sharp, Frank R. ;
Kuan, Chia-Yi .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (02) :566-583
[5]   Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury [J].
Akassoglou, K ;
Kombrinck, KW ;
Degen, JL ;
Strickland, S .
JOURNAL OF CELL BIOLOGY, 2000, 149 (05) :1157-1166
[6]   Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis [J].
Akassoglou, K ;
Adams, RA ;
Bauer, J ;
Mercado, P ;
Tseveleki, V ;
Lassmann, H ;
Probert, L ;
Strickland, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (17) :6698-6703
[7]   Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation [J].
Akassoglou, K ;
Yu, WM ;
Akpinar, P ;
Strickland, S .
NEURON, 2002, 33 (06) :861-875
[8]   Nervous system pathology: The fibrin perspective [J].
Akassoglou, K ;
Strickland, S .
BIOLOGICAL CHEMISTRY, 2002, 383 (01) :37-45
[9]   Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency [J].
Bugge, TH ;
Kombrinck, KW ;
Flick, MJ ;
Daugherty, CC ;
Danton, MJS ;
Degen, JL .
CELL, 1996, 87 (04) :709-719
[10]   Exacerbation of antigen-induced arthritis in urokinase-deficient mice [J].
Busso, N ;
Péclat, V ;
Van Ness, K ;
Kolodziesczyk, E ;
Degen, J ;
Bugge, T ;
So, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :41-50